Insights
Latest IR news and announcements for VEEVA SYSTEMS INC (VEEV).
Veeva Systems will conduct a virtual investor day on November 5, 2026, starting at 1:30 p.m. PT. The event will be broadcast live and archived on their investor relations website.
IQVIA has selected Veeva's clinical operations applications as enterprise standards for its studies, enhancing their partnership aimed at improving clinical trial efficiency and site connectivity, while allowing flexibility in technology choices for customers.
Veeva Systems will host the R&D and Quality Summit on October 20-21, featuring industry leaders discussing AI advancements in drug development, quality, and manufacturing. The event will include over 100 sessions with key insights from major biopharma companies.
Veeva Systems announces over 175 biotechs adopting Veeva Basics for streamlined operations, enhancing drug development efficiency and regulatory processes, allowing companies to scale technology infrastructure as they grow from startups to commercial entities.
Veeva Systems announced that its Data Quality System (DQS) has processed data for over 1 million subjects across more than 1,000 studies, automating workflows and enhancing clinical data management efficiency.
Veeva Systems announced that Servier is adopting Veeva OpenData across over 80 countries to create a unified, AI-ready data foundation, enhancing customer reference data management and driving efficiency in commercial operations.
Veeva Systems has introduced the Study Builder Agent, an AI tool that configures clinical studies in one day. It enhances EDC and DQS builds by utilizing existing standards, ensuring faster and more consistent processes for clinical trials.
Veeva Systems announces another top 20 biopharma commitment for its Vault CRM, now serving 190 customers and transforming industry engagement with healthcare professionals through innovative capabilities and deeper insights.
Veeva Systems has introduced the Falcon Router, designed to streamline the routing of safety reports and inquiries for biopharmaceutical companies, enhancing efficiency and speed in handling such reports. It will be available for early adopters in January 2027.
Amgen has selected Veeva Vault CRM for global use, enhancing its ability to deliver innovative medicines rapidly. This collaboration builds on over a decade of partnership, emphasizing Veeva's expertise in life sciences and commitment to innovation.
Veeva Systems announced its participation in two upcoming investor conferences, with presentations from its EVP of Strategy and CFO scheduled for September 9 and 10, 2026, respectively, available via webcast.
Veeva Systems introduces Falcon Safety, a new product designed to streamline adverse event management for biopharma companies, compatible with all E2B-compliant safety systems. The product aims to reduce costs and improve compliance and speed.
Veeva Systems announced its fiscal 2027 second quarter results, reporting total revenues of $928 million, an 18% increase year-over-year. The company also provided optimistic guidance for the upcoming quarter and fiscal year.
Veeva Systems announces Biogen's commitment to use Veeva Vault CRM globally, aiming to enhance the delivery of medicines. This partnership emphasizes shared values of customer experience and innovation in the life sciences sector.
Regeneron Pharmaceuticals has chosen Veeva Vault CRM to enhance its commercial operations, leveraging AI for improved field engagement and decision-making. This marks an expansion of their strategic partnership with Veeva Systems.
Eli Lilly has chosen Veeva Vault CRM for global use, aiming to enhance their commercial model using AI technology to improve patient access to medicines. This partnership expands their existing collaboration with Veeva Systems.
Veeva Systems will release its fiscal 2027 second quarter financial results on August 26, 2026, followed by a conference call. The results pertain to the quarter ending July 31, 2026.
Veeva Systems has launched Veeva EHS, a new application within Veeva Quality Cloud, aimed at improving environmental, health, and safety management through proactive risk identification and intelligent automation for manufacturing and testing sites.
Veeva Systems has acquired Copli and introduced Veeva Falcon MLR, a solution designed to automate and expedite the medical, legal, and regulatory review process, potentially reducing manual labor by over 70% within five years.
UCB has chosen Veeva Safety Suite to streamline its global safety operations, enhancing efficiency and compliance through automation and a unified platform for case processing and data management.